At the news
? NEUTRALIMPACT 2/10 6-K filed Oct 30, 2026 at 07:00 ET
Evaxion announced it received the 2026 International Prix Galien Award for its AI-Immunology platform as best digital health solution. This is a prestigious recognition but does not include any financial data, revenue, or changes to the company's pipeline or financial outlook.
- Evaxion awarded the 2026 International Prix Galien Award for AI-Immunology as best digital health solution.
- First time a Danish company has won this international award.
- The award is presented every two years and is often regarded as the equivalent of the Nobel Prize in biopharmaceutical research.
- Evaxion previously won the Prix Galien UK Award in June 2026 and the Nordic/European/Middle Eastern award in December 2025.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access